Related Experiment Video

Updated: Jun 24, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

Outbreak of wound botulism in injecting drug users

M Schroeter1, K Alpers, U Van Treeck

  • 1Institute for Public Health, North Rhine-Westphalia, Bielefeld and Münster, Germany.

Epidemiology and Infection
|April 9, 2009
PubMed

Insights

Injecting drug users (IDU) face a significant risk of wound botulism from contaminated injection drugs. This outbreak highlights the need for increased physician awareness and collaboration to prevent future cases in this population.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Toxicology

Background:

  • Wound botulism is a rare but serious condition caused by Clostridium botulinum toxin.
  • Injecting drug use is associated with various infectious disease risks.
  • An unusual cluster of wound botulism cases was observed in North Rhine-Westphalia, Germany.

Purpose of the Study:

  • To investigate an outbreak of wound botulism among injecting drug users.
  • To identify the source and transmission route of Clostridium botulinum.
  • To inform prevention and management strategies for future outbreaks.

Main Methods:

  • Epidemiological investigation of 16 notified wound botulism cases.
  • Clinical sample collection and laboratory cultivation of Clostridium botulinum.
  • Molecular typing of bacterial isolates to assess clonal relatedness.
  • Analysis of suspected contaminated heroin samples.

Main Results:

  • All 16 patients were identified as injecting drug users (IDU).
  • Clostridium botulinum was successfully isolated from six patients.
  • Molecular typing confirmed that the isolated strains were clonally identical.
  • Contaminated injection drugs were identified as the most probable source.

Conclusions:

  • Injecting drug users are at high risk for wound botulism due to contaminated drugs.
  • Enhanced physician awareness and public health surveillance are crucial.
  • Collaboration among public health bodies, outreach programs, and healthcare providers is essential for prevention and timely outbreak management.

More Related Videos

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

Related Concept Videos

Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...